Corteva Inc has a consensus price target of $63.15 based on the ratings of 31 analysts. The high is $78 issued by Mizuho on January 12, 2023. The low is $52 issued by Berenberg on November 27, 2023. The 3 most-recent analyst ratings were released by Mizuho, Deutsche Bank, and Deutsche Bank on June 18, 2024, June 12, 2024, and May 6, 2024, respectively. With an average price target of $63.33 between Mizuho, Deutsche Bank, and Deutsche Bank, there's an implied 15.64% upside for Corteva Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/18/2024 | Buy Now | 9.55% | Mizuho | Edlain Rodriguez | $61 → $60 | Maintains | Buy | Get Alert |
06/12/2024 | Buy Now | 18.68% | Deutsche Bank | David Begleiter | $65 → $65 | Maintains | Buy | Get Alert |
06/07/2024 | Buy Now | — | OTR Global | — | — | Downgrade | Mixed → Negative | Get Alert |
05/06/2024 | Buy Now | 18.68% | Deutsche Bank | David Begleiter | $62 → $65 | Maintains | Buy | Get Alert |
05/06/2024 | Buy Now | 16.85% | RBC Capital | Arun Viswanathan | $62 → $64 | Maintains | Outperform | Get Alert |
05/03/2024 | Buy Now | 18.68% | Canaccord Genuity | Bobby Burleson | $60 → $65 | Maintains | Buy | Get Alert |
05/03/2024 | Buy Now | 22.33% | Wells Fargo | Richard Garchitorena | $66 → $67 | Maintains | Overweight | Get Alert |
05/03/2024 | Buy Now | 22.33% | BMO Capital | Joel Jackson | $64 → $67 | Maintains | Outperform | Get Alert |
05/03/2024 | Buy Now | 25.98% | Oppenheimer | Kristen Owen | $67 → $69 | Maintains | Outperform | Get Alert |
05/02/2024 | Buy Now | 11.37% | Mizuho | Edlain Rodriguez | $56 → $61 | Maintains | Buy | Get Alert |
04/16/2024 | Buy Now | 22.33% | Oppenheimer | Kristen Owen | $62 → $67 | Maintains | Outperform | Get Alert |
04/12/2024 | Buy Now | 4.07% | JP Morgan | Jeffrey Zekauskas | $58 → $57 | Downgrade | Overweight → Neutral | Get Alert |
04/10/2024 | Buy Now | 5.9% | Barclays | Benjamin Theurer | $55 → $58 | Maintains | Equal-Weight | Get Alert |
04/09/2024 | Buy Now | 20.5% | Keybanc | Aleksey Yefremov | $63 → $66 | Maintains | Overweight | Get Alert |
03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson | — | Initiates | → Outperform | Get Alert |
02/12/2024 | Buy Now | 18.68% | Loop Capital | Christopher Kapsch | $57 → $65 | Upgrade | Hold → Buy | Get Alert |
02/02/2024 | Buy Now | 13.2% | Oppenheimer | Kristen Owen | $60 → $62 | Maintains | Outperform | Get Alert |
02/02/2024 | Buy Now | 16.85% | RBC Capital | Arun Viswanathan | $56 → $64 | Maintains | Outperform | Get Alert |
02/02/2024 | Buy Now | 15.03% | Keybanc | Aleksey Yefremov | $62 → $63 | Maintains | Overweight | Get Alert |
02/02/2024 | Buy Now | 18.68% | Wells Fargo | Richard Garchitorena | $54 → $65 | Maintains | Overweight | Get Alert |
02/02/2024 | Buy Now | 0.42% | Barclays | Benjamin Theurer | $50 → $55 | Maintains | Equal-Weight | Get Alert |
02/02/2024 | Buy Now | -3.23% | Exane BNP Paribas | Laurent Favre | → $53 | Upgrade | Underperform → Neutral | Get Alert |
02/01/2024 | Buy Now | 2.25% | Mizuho | Chris Parkinson | $59 → $56 | Maintains | Buy | Get Alert |
01/11/2024 | Buy Now | 16.85% | UBS | Joshua Spector | $65 → $64 | Maintains | Buy | Get Alert |
11/27/2023 | Buy Now | -5.06% | Berenberg | Aron Ceccarelli | $63 → $52 | Downgrade | Buy → Hold | Get Alert |
11/22/2023 | Buy Now | 15.03% | Roth MKM | Brian Wright | $82 → $63 | Maintains | Buy | Get Alert |
11/14/2023 | Buy Now | -8.71% | Barclays | Benjamin Theurer | $66 → $50 | Downgrade | Overweight → Equal-Weight | Get Alert |
11/10/2023 | Buy Now | 2.25% | RBC Capital | Arun Viswanathan | $61 → $56 | Maintains | Outperform | Get Alert |
11/10/2023 | Buy Now | 9.55% | Morgan Stanley | Vincent Andrews | $80 → $60 | Maintains | Overweight | Get Alert |
11/10/2023 | Buy Now | 13.2% | Keybanc | Aleksey Yefremov | $66 → $62 | Maintains | Overweight | Get Alert |
10/30/2023 | Buy Now | 5.9% | Fermium Research | Frank Mitsch | $72 → $58 | Maintains | Outperform | Get Alert |
10/30/2023 | Buy Now | 11.37% | RBC Capital | Arun Viswanathan | $67 → $61 | Maintains | Outperform | Get Alert |
10/30/2023 | Buy Now | 16.85% | BMO Capital | Joel Jackson | $70 → $64 | Maintains | Outperform | Get Alert |
10/24/2023 | Buy Now | 2.25% | Goldman Sachs | Adam Samuelson | $65 → $56 | Maintains | Neutral | Get Alert |
10/23/2023 | Buy Now | 20.5% | Wells Fargo | Richard Garchitorena | $73 → $66 | Maintains | Overweight | Get Alert |
10/20/2023 | Buy Now | 22.33% | Oppenheimer | Kristen Owen | → $67 | Upgrade | Perform → Outperform | Get Alert |
10/10/2023 | Buy Now | 29.63% | Mizuho | Chris Parkinson | $72 → $71 | Maintains | Buy | Get Alert |
09/05/2023 | Buy Now | 22.33% | UBS | Joshua Spector | $63 → $67 | Upgrade | Neutral → Buy | Get Alert |
08/17/2023 | Buy Now | 24.16% | Argus Research | Bill Selesky | $78 → $68 | Maintains | Buy | Get Alert |
08/14/2023 | Buy Now | 22.33% | Barclays | Benjamin Theurer | $70 → $67 | Maintains | Overweight | Get Alert |
08/07/2023 | Buy Now | 18.68% | JP Morgan | Jeffrey Zekauskas | $70 → $65 | Maintains | Overweight | Get Alert |
08/07/2023 | Buy Now | 33.28% | Wells Fargo | Richard Garchitorena | $74 → $73 | Maintains | Overweight | Get Alert |
08/07/2023 | Buy Now | 31.46% | Mizuho | Chris Parkinson | $74 → $72 | Maintains | Buy | Get Alert |
08/07/2023 | Buy Now | 20.5% | Keybanc | Aleksey Yefremov | $68 → $66 | Maintains | Overweight | Get Alert |
08/04/2023 | Buy Now | 35.11% | Credit Suisse | John Roberts | → $74 | Reiterates | Outperform → Outperform | Get Alert |
07/25/2023 | Buy Now | — | Redburn Partners | Tony Jones | — | Downgrade | Buy → Neutral | Get Alert |
07/13/2023 | Buy Now | 20.5% | RBC Capital | Arun Viswanathan | $73 → $66 | Maintains | Outperform | Get Alert |
07/11/2023 | Buy Now | 24.16% | Keybanc | Aleksey Yefremov | $70 → $68 | Maintains | Overweight | Get Alert |
06/28/2023 | Buy Now | 36.94% | Canaccord Genuity | Bobby Burleson | → $75 | Initiates | → Buy | Get Alert |
06/21/2023 | Buy Now | 46.07% | Morgan Stanley | Vincent Andrews | → $80 | Reiterates | → Overweight | Get Alert |
06/01/2023 | Buy Now | 27.81% | Barclays | Benjamin Theurer | $75 → $70 | Maintains | Overweight | Get Alert |
05/22/2023 | Buy Now | 22.33% | Vertical Research | Kevin McCarthy | → $67 | Upgrade | Hold → Buy | Get Alert |
05/05/2023 | Buy Now | 35.11% | Wells Fargo | Richard Garchitorena | $77 → $74 | Maintains | Overweight | Get Alert |
05/05/2023 | Buy Now | 38.76% | Mizuho | Chris Parkinson | $78 → $76 | Maintains | Buy | Get Alert |
04/21/2023 | Buy Now | 42.41% | Mizuho | Chris Parkinson | $76 → $78 | Maintains | Buy | Get Alert |
02/03/2023 | Buy Now | 40.59% | Wells Fargo | Richard Garchitorena | $78 → $77 | Maintains | Overweight | Get Alert |
02/03/2023 | Buy Now | 35.11% | Citigroup | PJ Juvekar | $72 → $74 | Maintains | Buy | Get Alert |
02/03/2023 | Buy Now | 27.81% | Keybanc | Aleksey Yefremov | $72 → $70 | Maintains | Overweight | Get Alert |
01/20/2023 | Buy Now | 31.46% | Citigroup | PJ Juvekar | $75 → $72 | Maintains | Buy | Get Alert |
01/19/2023 | Buy Now | 42.41% | Wells Fargo | Richard Garchitorena | → $78 | Initiates | → Overweight | Get Alert |
01/12/2023 | Buy Now | 42.41% | Mizuho | Christopher Parkinson | $76 → $78 | Maintains | Buy | Get Alert |
01/11/2023 | Buy Now | 46.07% | Morgan Stanley | Vincent Andrews | $70 → $80 | Maintains | Overweight | Get Alert |
01/11/2023 | Buy Now | 24.16% | B of A Securities | Steve Byrne | $64 → $68 | Upgrade | Underperform → Neutral | Get Alert |
11/17/2022 | Buy Now | 36.94% | Barclays | Benjamin Theurer | $71 → $75 | Maintains | Overweight | Get Alert |
11/16/2022 | Buy Now | 33.28% | UBS | Joshua Spector | $70 → $73 | Downgrade | Buy → Neutral | Get Alert |
11/15/2022 | Buy Now | 29.63% | Loop Capital | Christopher Kapsch | $70 → $71 | Downgrade | Buy → Hold | Get Alert |
11/07/2022 | Buy Now | 42.41% | RBC Capital | Arun Viswanathan | $72 → $78 | Maintains | Outperform | Get Alert |
11/07/2022 | Buy Now | 38.76% | BMO Capital | Joel Jackson | $72 → $76 | Maintains | Outperform | Get Alert |
11/07/2022 | Buy Now | 38.76% | Mizuho | Christopher Parkinson | $74 → $76 | Maintains | Buy | Get Alert |
11/04/2022 | Buy Now | 35.11% | Credit Suisse | John Roberts | $72 → $74 | Maintains | Outperform | Get Alert |
10/20/2022 | Buy Now | 35.11% | Mizuho | Christopher Parkinson | $69 → $74 | Maintains | Buy | Get Alert |
09/22/2022 | Buy Now | 27.81% | UBS | Joshua Spector | $66 → $70 | Maintains | Buy | Get Alert |
09/15/2022 | Buy Now | 36.94% | Deutsche Bank | David Begleiter | $68 → $75 | Maintains | Buy | Get Alert |
09/14/2022 | Buy Now | 31.46% | BMO Capital | Joel Jackson | $66 → $72 | Maintains | Outperform | Get Alert |
09/14/2022 | Buy Now | 31.46% | Keybanc | Aleksey Yefremov | $64 → $72 | Maintains | Overweight | Get Alert |
08/09/2022 | Buy Now | 31.46% | RBC Capital | Arun Viswanathan | $67 → $72 | Maintains | Outperform | Get Alert |
08/08/2022 | Buy Now | 25.98% | Mizuho | Christopher Parkinson | $68 → $69 | Maintains | Buy | Get Alert |
08/08/2022 | Buy Now | 25.98% | Citigroup | PJ Juvekar | $63 → $69 | Maintains | Buy | Get Alert |
08/08/2022 | Buy Now | 15.03% | JP Morgan | Jeffrey Zekauskas | $58 → $63 | Upgrade | Neutral → Overweight | Get Alert |
07/29/2022 | Buy Now | 24.16% | Mizuho | Christopher Parkinson | $67 → $68 | Maintains | Buy | Get Alert |
07/14/2022 | Buy Now | 24.16% | Credit Suisse | John Roberts | → $68 | Initiates | → Outperform | Get Alert |
06/01/2022 | Buy Now | 29.63% | Barclays | Benjamin Theurer | → $71 | Initiates | → Overweight | Get Alert |
05/31/2022 | Buy Now | 31.46% | Deutsche Bank | David Begleiter | $64 → $72 | Maintains | Buy | Get Alert |
05/23/2022 | Buy Now | 25.98% | Argus Research | Bill Selesky | $61 → $69 | Maintains | Buy | Get Alert |
05/06/2022 | Buy Now | — | JP Morgan | Jeffrey Zekauskas | — | Downgrade | Overweight → Neutral | Get Alert |
05/06/2022 | Buy Now | 16.85% | Keybanc | Aleksey Yefremov | $63 → $64 | Maintains | Overweight | Get Alert |
04/29/2022 | Buy Now | 22.33% | Mizuho | Christopher Parkinson | $60 → $67 | Maintains | Buy | Get Alert |
04/14/2022 | Buy Now | 5.9% | Vertical Research | Kevin McCarthy | → $58 | Downgrade | Buy → Hold | Get Alert |
04/14/2022 | Buy Now | 25.98% | Loop Capital | Christopher Kapsch | → $69 | Upgrade | Hold → Buy | Get Alert |
04/05/2022 | Buy Now | 15.03% | Keybanc | Aleksey Yefremov | $58 → $63 | Maintains | Overweight | Get Alert |
03/22/2022 | Buy Now | 20.5% | Citigroup | PJ Juvekar | $59 → $66 | Maintains | Buy | Get Alert |
02/04/2022 | Buy Now | 5.9% | Keybanc | Aleksey Yefremov | $55 → $58 | Maintains | Overweight | Get Alert |
11/15/2021 | Buy Now | 9.55% | Morgan Stanley | Vincent Andrews | — | Maintains | Overweight | Get Alert |
11/05/2021 | Buy Now | 0.42% | Keybanc | Aleksey Yefremov | — | Maintains | Overweight | Get Alert |
10/18/2021 | Buy Now | — | Loop Capital | Christopher Kapsch | — | Downgrade | Buy → Hold | Get Alert |
10/13/2021 | Buy Now | -3.23% | Mizuho | Christopher Parkinson | — | Initiates | → Buy | Get Alert |
10/08/2021 | Buy Now | -3.23% | Roth Capital | — | — | Initiates | → Buy | Get Alert |
09/01/2021 | Buy Now | 5.9% | Berenberg | — | — | Initiates | → Buy | Get Alert |
08/09/2021 | Buy Now | — | Monness, Crespi, Hardt | Chris Shaw | — | Upgrade | Sell → Neutral | Get Alert |
08/09/2021 | Buy Now | -1.41% | RBC Capital | Arun Viswanathan | — | Maintains | Outperform | Get Alert |
The latest price target for Corteva (NYSE:CTVA) was reported by Mizuho on June 18, 2024. The analyst firm set a price target for $60.00 expecting CTVA to rise to within 12 months (a possible 9.55% upside). 46 analyst firms have reported ratings in the last year.
The latest analyst rating for Corteva (NYSE:CTVA) was provided by Mizuho, and Corteva maintained their buy rating.
The last upgrade for Corteva Inc happened on February 12, 2024 when Loop Capital raised their price target to $65. Loop Capital previously had a hold for Corteva Inc.
The last downgrade for Corteva Inc happened on June 7, 2024 when OTR Global changed their price target from N/A to N/A for Corteva Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Corteva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Corteva was filed on June 18, 2024 so you should expect the next rating to be made available sometime around June 18, 2025.
While ratings are subjective and will change, the latest Corteva (CTVA) rating was a maintained with a price target of $61.00 to $60.00. The current price Corteva (CTVA) is trading at is $54.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.